US OptionsDetailed Quotes
ARCT250117P22500
- 5.87
- 0.000.00%
15min DelayClose Jan 13 16:00 ET
0.00High0.00Low
5.87Open5.87Pre Close0 Volume1 Open Interest22.50Strike Price0.00Turnover309.34%IV3.93%PremiumJan 17, 2025Expiry Date5.19Intrinsic Value100Multiplier3DDays to Expiry0.68Extrinsic Value100Contract SizeAmericanOptions Type-0.7559Delta0.0587Gamma2.96Leverage Ratio-0.2322Theta-0.0017Rho-2.24Eff Leverage0.0054Vega
Arcturus Therapeutics Stock Discussion
Sign in to post a comment
$Arcturus Therapeutics (ARCT.US)$at least I own one stock that's not going down today
4
1
$Arcturus Therapeutics (ARCT.US)$ hmm look what keeps going up... I posted this a few days ago you can go look this is a company that Bill gates's Bank rolling
2
$Arcturus Therapeutics (ARCT.US)$ this company is associated with Bill and Melinda Gates Foundation. they are in the process of developing a bird flu vaccination. the vaccine they're calling a pandemic injection.
out of California within the past couple of weeks you have Governor New scum talking about bird flu.. I've heard it mentioned on a couple of the fake news stations this past week. and now the self-proclaimed expert in medicine who believes that the world must be depopulated by 90% but i...
out of California within the past couple of weeks you have Governor New scum talking about bird flu.. I've heard it mentioned on a couple of the fake news stations this past week. and now the self-proclaimed expert in medicine who believes that the world must be depopulated by 90% but i...
7
19
2
$Arcturus Therapeutics (ARCT.US)$ wtf is happening bout to put this hoe down
1
Analysts maintain loss per share estimates for next year with no major changes to revenue estimates. However, the company's performance is expected to underperform the wider industry. The steady consensus price target indicates that reduced loss estimates may not positively impact the stock's long-term valuation.
Despite Arcturus Therapeutics Holdings Inc.'s strong run, its P/S ratio remains low due to a weak revenue outlook. Investors believe the potential for revenue improvement doesn't justify a higher P/S ratio, forming a barrier for the share price.
The recent improvement in total shareholder return could indicate that the business is getting better over time. However, there are 2 warning signs that investors should be aware of. The sentiment around the company seems to be positive lately.
No comment yet
EmotionOutOfEquation : how long this going to hit piper’s price target $140 in your opinion their trader’s success rate is only 38% ?